Superstar Investors Jump in on Celgene Spinout Celularity's $250M Funding Round Post author:Sam Post published:February 15, 2018 Post category:BioPharma Celularity is a biotech founded by stem cell pioneer Robert Hariri, MD, PhD. Source: BioSpace You Might Also Like 4 Top-Performing S&P 500 Biotech Stocks of 2017 December 27, 2017 TG Therapeutics Announces Follow-Up Data From The Chemo-Free Triple Combination Of TG-1101, TGR-1202, And Ibrutinib At The 53rd Annual Meeting Of The ASCO June 4, 2017 Boehringer Ingelheim, Roche Forge Partnership for Inflammatory Bowel Diseases December 18, 2017
TG Therapeutics Announces Follow-Up Data From The Chemo-Free Triple Combination Of TG-1101, TGR-1202, And Ibrutinib At The 53rd Annual Meeting Of The ASCO June 4, 2017
